⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3865583 | 1.00 | — | — | |
| SCHEMBL30131115 | 0.67 | — | — | |
| SCHEMBL6837629 | 0.67 | — | — | |
| SCHEMBL437539 | 0.65 | — | — | |
| SCHEMBL29772482 | 0.65 | — | — | |
| SCHEMBL11307161 | 0.64 | HPGDS (0.39) | — | |
| SCHEMBL20599960 | 0.64 | — | — | |
| SCHEMBL23069451 | 0.63 | EGFR (0.34) | — | |
| SCHEMBL29486327 | 0.63 | EGFR (0.34) | — | |
| SCHEMBL29486324 | 0.63 | EGFR (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025085598-A2 | PERSONALIZED REGENERATIVE CELLS | IMMORTA BIO, INC. (US) | 2025-04-24 | — | — | WO | claimed |
| WO-2025264721-A1 | ENHANCEMENT OF REGENERATIVE ACTIVITY BY INACTIVATION OF SENESCENT CELLS | IMMORTA BIO, INC. (US) | 2025-12-26 | — | — | WO | disclosed |
| WO-2025085598-A2 | PERSONALIZED REGENERATIVE CELLS | IMMORTA BIO, INC. (US) | 2025-04-24 | — | — | WO | disclosed |
| CN-110740996-B | Covalent small molecule DCN1 inhibitors and methods of treatment using the same | 密执安大学评议会 | 2024-01-09 | — | — | CN | disclosed |
| CN-115215886-A | Compounds and compositions as endosomal Toll-like receptor inhibitors | 诺华股份有限公司 | 2022-10-21 | — | — | CN | disclosed |